ANCA glomerulonephritis and vasculitis

JC Jennette, PH Nachman - … Journal of the American Society of …, 2017 - journals.lww.com
ANCA vasculitis has an associated autoimmune response that produces ANCAs that induce
distinct pathologic lesions. Pauci-immune necrotizing and crescentic GN is a frequent …

Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides

JC Jennette - Clinical and experimental nephrology, 2013 - Springer
The nomenclature and classification of vasculitis has been difficult and controversial for
many decades. This is problematic both for research on vasculitis as well as clinical care of …

Efficacy of remission-induction regimens for ANCA-associated vasculitis

U Specks, PA Merkel, P Seo, R Spiera… - … England Journal of …, 2013 - Mass Medical Soc
Background The 18-month efficacy of a single course of rituximab as compared with
conventional immunosuppression with cyclophosphamide followed by azathioprine in …

[HTML][HTML] EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

B Hellmich, B Sanchez-Alamo, JH Schirmer… - Annals of the …, 2024 - ard.bmj.com
Background Since the publication of the EULAR recommendations for the management of
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several …

Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease

JC Jennette, RJ Falk - Nature Reviews Rheumatology, 2014 - nature.com
Antineutrophil cytoplasmic autoantibodies (ANCAs) are the probable cause of a distinct form
of vasculitis that can be accompanied by necrotizing granulomatosis. Clinical and …

ANCA-associated vasculitis—clinical utility of using ANCA specificity to classify patients

D Cornec, ECL Gall, FC Fervenza… - Nature Reviews …, 2016 - nature.com
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a
heterogeneous group of rare syndromes characterized by necrotizing inflammation of small …

Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type

S Unizony, M Villarreal, EM Miloslavsky, N Lu… - Annals of the …, 2016 - ard.bmj.com
Objective To evaluate whether the classification of patients with anti-neutrophil cytoplasmic
antibody (ANCA)-associated vasculitis (AAV) according to ANCA type (anti-proteinase 3 …

[HTML][HTML] Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies …

BH Rovin, DJ Caster, DC Cattran, KL Gibson… - Kidney international, 2019 - Elsevier
In November 2017, the Kidney Disease: Improving Global Outcomes (KDIGO) initiative
brought a diverse panel of experts in glomerular diseases together to discuss the 2012 …

Acute glomerulonephritis

S Sethi, AS De Vriese, FC Fervenza - The Lancet, 2022 - thelancet.com
Glomerulonephritis is a heterogeneous group of disorders that present with a combination of
haematuria, proteinuria, hypertension, and reduction in kidney function to a variable degree …

The epidemiology of antineutrophil cytoplasmic autoantibody–associated vasculitis in Olmsted County, Minnesota: a twenty‐year US population–based study

A Berti, D Cornec, CS Crowson, U Specks… - Arthritis & …, 2017 - Wiley Online Library
Objective To estimate the annual incidence, prevalence, and mortality of antineutrophil
cytoplasmic autoantibody (ANCA)–associated vasculitis (AAV) and its subsets …